SS
TERN

Simplicity Solutions’s Terns Pharmaceuticals TERN Stock Holding History

Simplicity Solutions’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$67.8K Buy
+10,452
New +$55.3K ﹤0.01% 1031

Other funds holding TERN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Simplicity Solutions's TERN Position: Q4 2023 in Review

Simplicity Solutions opened a new position in Terns Pharmaceuticals (TERN) in Q4 2023: 10,452 shares worth $67.8K. The stake represents ﹤0.01% of the portfolio and ranks #1031 among its holdings.

103 funds tracked by Wall St. Rank hold TERN as of Q4 2023.

  • Simplicity Solutions held 10,452 shares of Terns Pharmaceuticals worth $67.8K as of Q4 2023.
  • Terns Pharmaceuticals was a new Simplicity Solutions position in Q4 2023.
  • Terns Pharmaceuticals made up ﹤0.01% of Simplicity Solutions's portfolio in Q4 2023, its #1031 holding.
  • 103 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.